mab2528 Search Results


human integrin alpha v beta 5 antibody  (Bio-Techne corporation)
99
Bio-Techne corporation human integrin alpha v beta 5 antibody
Human Integrin Alpha V Beta 5 Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mab2528/custom%40mab2528%4019505527?v=Bio-Techne+corporation
Average 99 stars, based on 1 article reviews
human integrin alpha v beta 5 antibody - by Bioz Stars, 2026-07
99/100 stars
  Buy from Supplier
avb5 mab2528 integrins  (R&D Systems)
93
R&D Systems avb5 mab2528 integrins
Fig. 5. ADAM9D binds to MDA-MB-231 tumor breast cells by b1, a3, aVb3, <t>aVb5</t> and a2 integrins. Ninety six well plates were coated with ADAM9D (10 mg/ml) overnight at 4 C. After blocking with 1% BSA, the CMFDA-labeled MDA-MB-231 cells (1 105 cells/ well) previously incubated (30 min, 37 C) or not (control bar) with different anti- bodies (20 mg/well) were added to each well. The plates were incubated at 37 C for 30 min, washed, lysed and read as in Fig. 2. Results are expressed as mean SEM of three independent experiments. The results were normalized by the ADAM9D (control) values which were considered as 100% adhesion The p value was determined using the using Dunnett’s test comparing antibodies bars with the control bar (*p < 0.05; **p < 0.01; ***p < 0.001).
Avb5 Mab2528 Integrins, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mab2528/pm19505527-47-16-22?v=R%26D+Systems
Average 93 stars, based on 1 article reviews
avb5 mab2528 integrins - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

Image Search Results


Fig. 5. ADAM9D binds to MDA-MB-231 tumor breast cells by b1, a3, aVb3, aVb5 and a2 integrins. Ninety six well plates were coated with ADAM9D (10 mg/ml) overnight at 4 C. After blocking with 1% BSA, the CMFDA-labeled MDA-MB-231 cells (1 105 cells/ well) previously incubated (30 min, 37 C) or not (control bar) with different anti- bodies (20 mg/well) were added to each well. The plates were incubated at 37 C for 30 min, washed, lysed and read as in Fig. 2. Results are expressed as mean SEM of three independent experiments. The results were normalized by the ADAM9D (control) values which were considered as 100% adhesion The p value was determined using the using Dunnett’s test comparing antibodies bars with the control bar (*p < 0.05; **p < 0.01; ***p < 0.001).

Journal: Biochimie

Article Title: Inhibition of platelets and tumor cell adhesion by the disintegrin domain of human ADAM9 to collagen I under dynamic flow conditions.

doi: 10.1016/j.biochi.2009.05.012

Figure Lengend Snippet: Fig. 5. ADAM9D binds to MDA-MB-231 tumor breast cells by b1, a3, aVb3, aVb5 and a2 integrins. Ninety six well plates were coated with ADAM9D (10 mg/ml) overnight at 4 C. After blocking with 1% BSA, the CMFDA-labeled MDA-MB-231 cells (1 105 cells/ well) previously incubated (30 min, 37 C) or not (control bar) with different anti- bodies (20 mg/well) were added to each well. The plates were incubated at 37 C for 30 min, washed, lysed and read as in Fig. 2. Results are expressed as mean SEM of three independent experiments. The results were normalized by the ADAM9D (control) values which were considered as 100% adhesion The p value was determined using the using Dunnett’s test comparing antibodies bars with the control bar (*p < 0.05; **p < 0.01; ***p < 0.001).

Article Snippet: For competition assays the monoclonal antibodies directed against human a2 (MAB1233), a6 (MAB13501), b1 (MAB17781) and aVb5 (MAB2528) integrins were obtained from R&D Systems (Minneapolis, MN, USA).

Techniques: Blocking Assay, Labeling, Incubation, Control